Current Report Filing (8-k)
01 December 2021 - 8:36AM
Edgar (US Regulatory)
0001622244
false
12-31
0001622244
2021-11-23
2021-11-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
|
November
23, 2021
|
|
One
World Products, Inc.
|
(Exact
name of registrant as specified in charter)
|
Nevada
|
|
333-200529
|
|
61-1744826
|
(State or other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
3471
West Oquendo Road, Suite 301 Las Vegas, NV
|
|
89118
|
(Address
of principal executive offices)
|
|
(zip
code)
|
Registrant’s telephone number, including area code:
|
(800)
605-3201
|
|
One
World Pharma, Inc.
(Former
name or form former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any
of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.03.
|
Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year
|
On
November 23, 2021, One World Pharma, Inc. (the “Company”) changed its name to One World Products, Inc. through the merger
of One World Products, Inc., a recently formed Nevada corporation wholly-owned by the Company, with and into the Company (the “Name
Change Merger”) pursuant to the applicable provisions of the Nevada Revised Statutes (“NRS”). As permitted by the NRS,
the articles of merger filed with the Secretary of State of the state of Nevada to effect the Name Change Merger amended Article I of
the Company’s Articles of Incorporation to change the Company’s name to “One World Products, Inc.”
The
Name Change Merger was effected pursuant to an Agreement and Plan of Merger dated October 11, 2021, which has been filed as Exhibit 2.1
to this Current Report on Form 8-K, and which is incorporated herein by reference. The Name Change Merger was effected solely to effect
the change of the Company’s name, and had no effect on our officers, directors, operations, assets or liabilities.
The
Name Change Merger was approved by the Financial Industry Regulatory Authority (“FINRA”) on November 30, 2021 and will become
effective in the marketplace at the open of business on December 1, 2021.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
One World Pharma, Inc.
|
|
|
|
Date: November 30, 2021
|
|
|
|
|
By:
|
/s/
Vahe Gabriel
|
|
Name:
|
Vahe
Gabriel
|
|
Title:
|
Chief
Financial Officer
|
One World Products (QB) (USOTC:OWPC)
Historical Stock Chart
From Apr 2024 to May 2024
One World Products (QB) (USOTC:OWPC)
Historical Stock Chart
From May 2023 to May 2024